查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654370

美國周邊血管血管造影術劑市場規模、佔有率、趨勢分析報告：按方式、產品、最終用途和細分市場預測，2025 年至 2030 年

U.S. Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, Magnetic Resonance Imaging, CT/X-ray), By Product, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國周邊血管造影術劑市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，美國周邊血管造影術劑市場規模預計到2030年將達到3.3181億美元，2025年至2030年期間的複合年成長率為6.29%。血管疾病的發生率日益上升，尤其是在老齡化社會以及患有糖尿病、高血壓和肥胖症等文明病的患者中，推動了對先進診斷成像的需求。周邊血管造影術利用顯影劑增強血管的可見度，對於早期發現和準確診斷周邊動脈疾病和其他循環系統疾病至關重要。

糖尿病、肥胖症、高血壓和吸煙等與文明病在世界各地變得越來越普遍。這些情況顯著增加了罹患周邊血管疾病的風險。例如，糖尿病和高血壓會損害血管並增加血管併發症的可能性。隨著全球範圍內患有這些文明病的患者數量不斷增加，對診斷影像的需求也相應增加。周邊血管造影術利用顯影劑提供清晰、詳細的血管影像，對於診斷這些疾病並及時進行醫療干預至關重要。文明病盛行率的增加直接推動了對血管造影術劑的需求。據葉迪特佩大學醫院稱，到 2025 年，高血壓患者數量預計將達到 15 億。 60 歲以上的人中，有三分之一患有高血壓。

然而，限制市場成長的主要因素之一是診斷影像（尤其是血管造影術）的成本高昂。先進的影像技術，例如用於周邊血管造影術的技術，需要昂貴的設備、熟練的工作人員和特殊的顯影劑。高昂的費用可能會限制人們獲得這些手術的機會，特別是在醫療預算較低的地區，並會使一些患者和醫療服務提供者不願意選擇診斷性血管造影術。此外，保險不足的患者可能面臨自付費用，從而減少對這些服務的整體需求。

美國血管造影術造影劑市場報告重點

  • 根據產品，CT/X光領域預計將在 2024 年佔據市場主導地位，並在 2025 年至 2030 年期間實現顯著的複合年成長率。先天性心臟疾病（CHD）盛行率的上升導致CT血管攝影的需求大幅增加。
  • 根據方式，市場以碘基顯影劑，這種造影劑在X光、CT和血管造影術等顯像模式中可以非常有效地提高血管的可見度。
  • 根據最終用途，醫院部門預計將在 2024 年佔據市場主導地位，並在預測期內實現顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章美國周邊血管血管造影術劑市場變數、趨勢與範圍

  • 市場體系展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國周邊血管血管造影術顯影劑市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章美國周邊血管造影術造影劑市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 美國血管血管造影術劑市場波動分析
  • 美國周邊血管血管造影術顯影劑市場規模及趨勢分析（依產品分類），2018 年至 2030 年
  • CT/X光
  • 磁振造影
  • 超音波

第5章美國周邊血管血管造影術劑市場按方式、估計和趨勢分析

  • 細分儀表板
  • 美國血管血管造影術劑市場波動分析
  • 2018 年至 2030 年美國周邊血管血管造影術劑市場規模及趨勢分析（依治療方式）
  • 碘顯影劑
  • 钆顯影劑
  • 微氣泡

第6章美國外周血血管造影術造影劑市場：按最終用途分類的估計和趨勢分析

  • 細分儀表板
  • 美國血管血管造影術劑市場波動分析
  • 2018 年至 2030 年美國周邊血管血管造影術劑市場規模及趨勢分析（依最終用途）
  • 醫院
  • 診斷影像中心
  • 研究所
  • 其他

第7章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024 年企業市場分析
  • 主要認證提供者/計畫所有者列表
  • 公司簡介/上市公司
    • Lantheus Holdings, Inc.
    • Guerbet
    • Bracco
    • Bayer
    • GE HealthCare
    • Fresenius Kabi USA
Product Code: GVR-4-68040-506-5

U.S. Peripheral Vascular Angiography Contrast Media Market Growth & Trends:

The U.S. peripheral vascular angiography contrast media market size is anticipated to reach USD 331.81 million by 2030 expanding at a CAGR of 6.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of vascular diseases, particularly among the aging population and individuals with lifestyle-associated conditions such as diabetes, hypertension, and obesity, is driving demand for advanced diagnostic imaging. Peripheral vascular angiography procedures, which utilize contrast agents to enhance the visibility of blood vessels, are essential for the early detection and accurate diagnosis of peripheral artery disease and other circulatory disorders.

Lifestyle-associated diseases, such as diabetes, obesity, hypertension, and smoking, are becoming more common worldwide. These conditions significantly increase the risk of developing peripheral vascular diseases. For instance, diabetes and hypertension can damage blood vessels, leading to a higher likelihood of vascular complications. As the number of individuals living with these lifestyle-related conditions continues to grow globally, there is an associated rise in the demand for diagnostic imaging. Peripheral vascular angiography, which utilizes contrast media to provide clear and detailed images of the blood vessels, is crucial in diagnosing these conditions and enabling timely medical interventions. This increasing prevalence of lifestyle-related disorders directly drives the demand for angiography contrast media. According to Yeditepe University Hospital, by 2025, hypertension patients are expected to reach 1.5 billion. 1 in 3 people over the age of 60 have hypertension.

However, one of the major factors restraining the growth of the market is the high cost of diagnostic imaging procedures, particularly angiography. Advanced imaging technologies, such as those used in peripheral vascular angiography, require expensive equipment, skilled personnel, and specialized contrast media. This high cost can limit access to these procedures, particularly in regions with lower healthcare budgets, and may deter some patients or healthcare providers from opting for diagnostic angiography. Moreover, patients without adequate insurance coverage may face out-of-pocket costs, reducing the overall demand for these services.

U.S. Peripheral Vascular Angiography Contrast Media Market Report Highlights:

  • Based on the product, The CT/X-ray segment dominated the market in 2024 and is expected to register a significant CAGR from 2025 to 2030. The rising prevalence of congenital heart diseases (CHDs) significantly increases the demand for CT angiography.
  • Based on the modality, Iodinated contrast media dominate the market due to their high efficacy in enhancing the visibility of blood vessels in imaging modalities such as X-ray, CT, and angiography.
  • Based on end use, the hospital segment dominated the market in 2024, and it is expected to witness significant growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Vascular Angiography Contrast Media Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing burden of peripheral artery disease
      • 3.2.1.2. Rising demand for medical imaging
      • 3.2.1.3. Increasing prevalence of aging population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with angiography procedures
      • 3.2.2.2. Complications associated with the use of contrast agent during procedures
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising number of clinical trials
      • 3.2.3.2. Growing prevalence of lifestyle associated disorders
      • 3.2.3.3. Increasing regulatory approvals and launches among developed countries
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Peripheral Vascular Angiography Contrast Media Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power Of Suppliers
      • 3.3.1.2. Bargaining Power Of Buyers
      • 3.3.1.3. Threat Of Substitutes
      • 3.3.1.4. Threat Of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. U.S. Peripheral Vascular Angiography Contrast Media Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
  • 4.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. CT/X-ray
    • 4.4.1. CT/X-ray U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Magnetic Resonance Imaging
    • 4.5.1. Magnetic Resonance Imaging U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Ultrasound
    • 4.6.1. Ultrasound U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Vascular Angiography Contrast Media Market: Modality Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
  • 5.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 5.4. Iodinated Contrast Media
    • 5.4.1. Iodinated Contrast Media U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gadolinium-based Contrast Media
    • 5.5.1. Gadolinium-based Contrast Media U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Microbubble
    • 5.6.1. Microbubble U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Vascular Angiography Contrast Media Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
  • 6.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic Imaging Centers U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Research Institutes U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. List of Key Certification Providers/Scheme Owners
  • 7.5. Company Profiles/Listing
    • 7.5.1. Lantheus Holdings, Inc.
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product Type benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Guerbet
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product Type benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Bracco
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product Type benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Bayer
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product Type benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. GE HealthCare
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product Type benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Fresenius Kabi USA
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product Type benchmarking
      • 7.5.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Peripheral Vascular Angiography Contrast Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Peripheral Vascular Angiography Contrast Media Market, by Modality, 2018 - 2030 (USD Million)
  • Table 5 U.S. Peripheral Vascular Angiography Contrast Media Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Participant's Overview
  • Table 7 Financial Performance
  • Table 8 Product Benchmarking
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Peripheral Vascular Angiography Contrast Media Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Product Marketplace: Key Takeaways
  • Fig. 14 U.S. Peripheral Vascular Angiography Contrast Media Market, for CT/X-ray, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Peripheral Vascular Angiography Contrast Media Market, for Magnetic Resonance Imaging, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Peripheral Vascular Angiography Contrast Media Market, for Ultrasound, 2018 - 2030 (USD Million)
  • Fig. 17 Modality Marketplace: Key Takeaways
  • Fig. 18 U.S. Peripheral Vascular Angiography Contrast Media Market, for Iodinated Contrast Media, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Peripheral Vascular Angiography Contrast Media Market, for Gadolinium-based Contrast Media, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Peripheral Vascular Angiography Contrast Media Market, for Microbubble, 2018 - 2030 (USD Million)
  • Fig. 21 End Use Marketplace: Key Takeaways
  • Fig. 22 U.S. Peripheral Vascular Angiography Contrast Media Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Peripheral Vascular Angiography Contrast Media Market, for Diagnostic Imaging Centers, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Peripheral Vascular Angiography Contrast Media Market, for Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Peripheral Vascular Angiography Contrast Media Market, for Others, 2018 - 2030 (USD Million)